IA
LABU icon

IFP Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

IFP Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$9K – 4503
2024
Q4 		$9K Buy
+100
New +$11.8K ﹤0.01% 2565
2023
Q2 		– Sell
-8
Closed -$15.2K – 3516
2023
Q1 		$15.2K Sell
8
-737
-99% -$99.9K ﹤0.01% 2128
2022
Q4 		$1.5M Sell
745
-4,403
-86% -$614K 0.04% 461
2022
Q3 		$10.4M Buy
5,148
+948
+23% +$174K 0.27% 74
2022
Q2 		$8.49M Hold
4,200
– – 0.27% 83
2022
Q1 		$8.49M Buy
+4,200
New +$1.58M 0.27% 83
2017
Q4 		– Sell
-4
Closed -$6K – 3963
2017
Q3 		$6K Buy
+4
New +$5.55K ﹤0.01% 3307

Other funds holding LABU

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

IFP Advisors's LABU Position: Q1 2025 in Review

IFP Advisors sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2025, closing a stake of 100 shares — an estimated $9K sold.

IFP Advisors first reported a position in LABU in Q3 2017 and held it in 7 quarters. The position peaked at $10.4M in Q3 2022. 34 funds tracked by Wall St. Rank hold LABU as of Q1 2025.

  • IFP Advisors reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2025 after selling out during the quarter.
  • IFP Advisors sold 100 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2025, an estimated $9K.
  • IFP Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2017 and held it in 7 quarters.
  • IFP Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $10.4M in Q3 2022.
  • 34 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2025.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.